Loading…
Based on limited metadata without access to the full letter text, this FDA Warning Letter was issued to Izeen Pharma Inc, a pharmaceutical company, on May 16, 2019. The letter addresses violations related to drug products, though the specific nature of the violations cannot be determined from the available metadata as no subject line details are provided. The enforcement action falls under FDA's drug regulatory authority, though the specific issuing office is not identified in the available information. Without the complete letter contents, the particular manufacturing, quality, or compliance issues cited cannot be specified.